Prelude Capital Management’s Enzo Biochem, Inc. ENZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-45,500
| Closed | -$94K | – | 1842 |
|
|
2022
Q2 | $94K | Hold |
45,500
| – | – | ﹤0.01% | 1216 |
|
|
2022
Q1 | $132K | Hold |
45,500
| – | – | ﹤0.01% | 1069 |
|
|
2021
Q4 | $146K | Hold |
45,500
| – | – | ﹤0.01% | 1287 |
|
|
2021
Q3 | $161K | Hold |
45,500
| – | – | ﹤0.01% | 1073 |
|
|
2021
Q2 | $144K | Sell |
45,500
-4,500
| -9% | -$14.2K | ﹤0.01% | 1150 |
|
|
2021
Q1 | $172K | Sell |
50,000
-50,000
| -50% | -$172K | ﹤0.01% | 949 |
|
|
2020
Q4 | $252K | Hold |
100,000
| – | – | 0.01% | 582 |
|
|
2020
Q3 | $211K | Buy |
+100,000
| New | +$211K | 0.01% | 487 |
|
|
2018
Q2 | – | Sell |
-1,488
| Closed | -$8K | – | 1717 |
|
|
2018
Q1 | $8K | Buy |
+1,488
| New | +$8K | ﹤0.01% | 1227 |
|
|
2017
Q2 | – | Sell |
-28,800
| Closed | -$241K | – | 1810 |
|
|
2017
Q1 | $241K | Buy |
28,800
+8,700
| +43% | +$72.8K | 0.02% | 464 |
|
|
2016
Q4 | $139K | Buy |
20,100
+13,000
| +183% | +$89.9K | 0.02% | 677 |
|
|
2016
Q3 | $36K | Sell |
7,100
-6,100
| -46% | -$30.9K | ﹤0.01% | 1085 |
|
|
2016
Q2 | $79K | Buy |
13,200
+900
| +7% | +$5.39K | 0.01% | 799 |
|
|
2016
Q1 | $56K | Sell |
12,300
-2,200
| -15% | -$10K | 0.01% | 873 |
|
|
2015
Q4 | $65K | Sell |
14,500
-6,400
| -31% | -$28.7K | 0.01% | 910 |
|
|
2015
Q3 | $66K | Hold |
20,900
| – | – | 0.01% | 896 |
|
|
2015
Q2 | $63K | Sell |
20,900
-4,300
| -17% | -$13K | 0.01% | 994 |
|
|
2015
Q1 | $74K | Sell |
25,200
-4,500
| -15% | -$13.2K | 0.01% | 1092 |
|
|
2014
Q4 | $132K | Buy |
29,700
+1,400
| +5% | +$6.22K | 0.02% | 844 |
|
|
2014
Q3 | $146K | Buy |
+28,300
| New | +$146K | 0.02% | 786 |
|